Inhibin/activin βB-subunit expression in pheochromocytomas favors benign diagnosis

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 5, 2001, Pages 2231-2235

  Salmenkivi, Kaisa ^a,b   Arola, Johanna ^a,b   Voutilainen, Raimo ^a,b,c   Ilvesmäki, Vesa ^b   Haglund, Caj ^b   Kahri, Arvi I ^a,b   Heikkilä, Päivi ^a,b   Liu, Jianqi ^a,b,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; INHIBIN; MYELOPID; PROTEIN SUBUNIT; ACTIVIN; INHIBIN BETA A SUBUNIT; MESSENGER RNA; PEPTIDE;

ADRENAL MEDULLA; ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RNA ANALYSIS; TUMOR VOLUME; ADOLESCENT; ADRENAL TUMOR; AGED; CHEMISTRY; GENETICS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NORTHERN BLOTTING;

ACTIVINS; ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; BLOTTING, NORTHERN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBIN-BETA SUBUNITS; INHIBINS; MALE; MIDDLE AGED; PEPTIDES; PHEOCHROMOCYTOMA; RNA, MESSENGER;

EID: 0034744030     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.5.2231     Document Type: Article

References (19)

1. Melicow MM. 1977 One hundred cases of pheochromocytoma (107 tumors) at the Columbia-Presbyterian Medical Center, 1926-1976: a clinicopathological analysis. Cancer. 40:1987-2004.
2. van Heerden JA, Sheps SG, Hamberger B, Sheedy PFI, Poston JG, ReMine WH. 1982 Pheochromocytoma: current status and changing trends. Surgery. 91:367-373.
3. Neville AM, ed. 1969 The adrenal medulla. Baltimore: Williams & Wilkins; 217-324.
4. Linnoila RI, Keiser HR, Steinberg SM, Lack EE. 1990 Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Hum Pathol. 21:1168-1180.
5. Ying S-Y. 1988 Inhibins, activins and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev. 9:267-293.
6. Meunier H, Rivier C, Evans RM, Vale W. 1988 Gonadal and extragonadal expression of inhibin α, βA and βB subunits in various tissues predicts diverse functions. Proc Natl Acad Sci USA. 85:247-251.
7. De Jong FH, Grootenhuis AJ, Steenbergeen J, et al. 1990 Inhibin immunoreactivity in gonadal and non-gonadal tumors. J Steroid Biochem Mol Biol. 37:863-866.
8. Voutilainen R, Erämaa M, Ritvos O. 1991 Hormonally regulated inhibin gene expression in human fetal and adult adrenals. J Clin Endocrinol Metab. 73:1026-1030.
9. Munro LMA, Kennedy A, McNicol AM. 1999 The expression of inhibin/activin subunits in the human adrenal cortex and its tumors. J Endocrinol. 161:341-347.
10. Arola J, Liu J, Heikkilä P, et al. 2000 Expression of inhibin α in adrenocortical tumours reflects the hormonal status of the neoplasm. J Endocrinol. 165:223-229.
11. McCluggage WG, Burton J, Maxwell P, Sloan JM. 1998 Immunohistochemical staining of normal, hyperplastic, and neoplastic adrenal cortex with a monoclonal antibody against α inhibin. J Clin Pathol. 51:114-116.
12. Spencer SJ, Rabinovici J, Mesiano S, Goldsmith PC, Jaffe RB. 1992 Activin and inhibin in the human adrenal gland. Regulation and differential effects in fetal and adult cells. J Clin Invest. 90:142-149.
13. Liu J, Kahri AI, Heikkilä P, Blum WF, Voutilainen R. 1994 Glucocorticoids increase insulin-like growth factor-II mRNA accumulation in cultured human phaechromocytoma cells. J Endocrinol. 142:29-35.
14. Mason AJ, Niall HD, Seeburg PH. 1986 Structure of two human ovarian inhibins. Biochem Biophys Res Commun. 135:957-964.
15. Arnheim N. 1979 Characterization of mouse ribosomal gene fragments purified by molecular cloning. Gene. 7:83-96.
16. Neumann HPH, Berger DP, Sigmund G, et al. 1993 Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. N Engl J Med. 329:1531-1538.
17. Van der Harst E, de Krijger RR, Bruining HA, et al. 1998 Prognostic value of RET proto-oncogene point mutations in malignant and benign, sporadic phaeochromocytomas. Int J Cancer. 79:537-540.
18. Bravo EL. 1994 Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev. 15:356-368.
19. Yoshimoto Y, Naruse M, Zeng Z, et al. 1998 The relative high frequency of p53 gene mutations in multiple and malignant phaeochromocytomas. J Endocrinol. 159:247-255.